Evaluation of calcium level in patients with diabetes mellitus according to the examination in the mobile medical center (Diamodule)

Cover Page

Cite item

Full Text

Abstract

Background. Diabetes mellitus (DM) is characterized by multiple risk factors for the combined development of disorders of phosphorus-calcium metabolism, due to more frequent overweight, decreased renal filtration function and vitamin D deficiency in this category of patients. Aim. To assess the level of calcium in blood serum and its correlations with parameters of carbohydrate metabolism, body mass index (BMI) and renal function in patients with type 1 and type 2 diabetes. Materials and methods. The object of the study: adult patients with type 1 diabetes (T1DM) and type 2 diabetes (T2DM) >18 years old who underwent examination in Diamodule (n=294) in 2019 in the Voronezh region, who were additionally tested for serum calcium. The examination at the mobile medical center includes: assessment of anthropometric data (height, weight, BMI), biochemical data of blood lipids and creatinine levels with calculation of glomerular filtration rate (GFR-EPI), albuminuria and the albumin/creatinine in a single portion of urine, measurement of glycated hemoglobin (HbA1c), blood pressure, electrocardiogram, consultation with a cardiologist, ophthalmologist, specialist of the Diabetic Foot office, diabetologist. All biochemical parameters was carried out using commercial kits on a biochemical express analyzer Spotchem EZ ArkraySP-4430. Determination of HbA1c, albuminuria, albumin/creatinine was performed by immunochemical method on a DCA Vantage analyzer. Data analysis was carried out using the Statistica v.13.3 software package (TIBCO Software Inc., USA). The results are presented as medians and quartiles [25; 75], the level of reliability is taken as p<0.05. Results. Hypocalcemia (serum calcium level less 2.15 mmol/L) was detected in 88.3% of patients with T1DM and 73.6% of patients with T2DM. The level of serum calcium in T1DM was 1.96 [1.83; 2.07], in T2DM - 2.04 [1.97; 2.16] (p<0.001) with significant differences in GFR: in T1DM 69.6 [57.8; 82.5], with T2DM 50.5 [44.1; 59.9] (p<0.001). We observed correlation between GFR and calcium level r=-0.3 (p<0.05,). GFR<60 ml/min/1.73 m2 was observed in 30.5% of T1DM patients, in 75.0% of T2DM. The HbA1c in T1DM was 8.7% [7.7; 9.8], in T2DM - 8.3% [6.8; 9.4] (p=0.01). Obesity was revealed in T1DM in 12.3%, in T2DM in 71.4%; the median BMI in T1DM was 25.5 kg/m2 [21.9; 28.4], in T2DM - 33.2 kg/m2 [29.7; 37.9]. There was correlation between BMI and calcium level r=0.26 (p<0.05). Conclusion. The results of the study revealed a high prevalence of hypocalcemia among patients with diabetes, the most pronounced in type 1 diabetes. In the presence of a correlation between calcium and GFR, there was a high incidence of hypocalcemia in patients with T1DM, even in the absence of a significant decrease in GFR, which may indicate to additional risk factors. Since the assessment of the level of calcium is not included in the list of standard clinical examination, it is recommended to include this parameter and conduct regular screening in risk groups, which include patients with diabetes. More extensive research is needed to analyze the factors.

About the authors

Anna V. Zheleznyakova

Endocrinology Research Centre

Email: azhelez@gmail.com
канд. мед. наук, ст. науч. сотр. отд-ния эпидемиологии Moscow, Russia

Victoriya L. Volodicheva

Endocrinology Research Centre

науч. сотр. отд-ния патологии околощитовидных желез Moscow, Russia

Olga K. Vikulova

Endocrinology Research Centre

канд. мед. наук, доц., зав. отд-нием эпидемиологии Moscow, Russia

Alexey A. Serkov

Endocrinology Research Centre

вед. инженер Moscow, Russia

Anna K. Eremkina

Endocrinology Research Centre

канд. мед. наук, ст. науч. сотр. Moscow, Russia

Marina V. Shestakova

Endocrinology Research Centre

акад. РАН Moscow, Russia

Natalia G. Mokrysheva

Endocrinology Research Centre

чл.-кор. РАН, д-р мед. наук, проф., дир. Moscow, Russia

References

  1. Дедов И.И., Шестакова М.В., Викулова О.К., и др. Атлас регистра сахарного диабета Российской Федерации. Статус 2018 г. Сахарный диабет. 2019;22(2S):4-61
  2. Шестакова М.В., Викулова О.К., Железнякова А.В., и др. Эпидемиология сахарного диабета в Российской Федерации: что изменилось за последнее десятилетие? Терапевтический архив. 2019;91(10):4-13
  3. Шамхалова М.Ш., Викулова О.К., Железнякова А.В., и др. Эпидемиология хронической болезни почек в Российской Федерации по данным Федерального регистра взрослых пациентов с сахарным диабетом (2013-2016 гг.). Сахарный диабет. 2018;21(3):160-9
  4. Ермоленко В.М., Ветчинникова О.Н., Волгина Г.В., и др. Минеральные и костные нарушения при хронической болезни почек. Национальные рекомендации. 2015
  5. Moldovan D, Rusu C, Kacso IM, et al. Mineral and bone disorders, morbidity and mortality in end-stage renal failure patients on chronic dialysis. Clujul Med. 2016;89(1):94-103. doi: 10.15386/cjmed-515
  6. Seifert ME, Hruska KA. The Kidney-Vascular-Bone Axis in the Chronic Kidney Disease-Mineral Bone Disorder. Transplantation. 2016;100(3):497-505. doi: 10.1097/TP.0000000000000903
  7. Lecka-Czernik B. Diabetes, bone and glucose-lowering agents: basic biology. Diabetologia. 2017;60:1163-9. doi: 10.1007/s00125-017-4269-4
  8. Дедов И.И., Шестакова М.В., Сунцов Ю.И., и др. Результаты реализации подпрограммы «Сахарный диабет» Федеральной целевой программы «Предупреждение и борьба с социально значимыми заболеваниями 2007-2012 годы». Сахарный диабет. 2013;16(2S):1-48
  9. Викулова О.К., Железнякова А.В., Исаков М.А., и др. Динамический анализ состояния углеводного обмена в субъектах Российской Федерации по данным мобильного медицинского центра (Диамодуль) и регистра сахарного диабета Российской Федерации. Сахарный диабет. 2020;23(2):104-12
  10. Железнякова А.В., Викулова О.К., Серков А.А., и др. Динамический мониторинг сердечно-сосудистых заболеваний у пациентов с сахарным диабетом по данным обследования в мобильном медицинском центре (Диамодуль) в регионах России. Consilium Medicum. 2020;22(10): 39-44
  11. Дедов И.И., Шестакова М.В., Майоров А.Ю., и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Вып. 9. Сахарный диабет. 2019;22(1S1):1-144
  12. Бирагова М.С., Грачева С.А., Мартынов С.А. Нарушения фосфорно-кальциевого обмена у пациентов с сахарным диабетом и хронической болезнью почек. Сахарный диабет. 2012;15(4):74-80
  13. Хантакова Е.А., Хамнуева Л.Ю., Орлова Г.М. Анализ фосфорно-кальциевого обмена и функции паращитовидных желез у больных сахарным диабетом 1 типа. Сахарный диабет. 2013;16(4):33-7
  14. Шепелькевич А.П. Состояние показателей фосфорно-кальциевого обмена у пациентов с сахарным диабетом 1-го типа. Военная медицина. 2012;25:93-102
  15. Bonds DE, Larson JC, Schwartz AV, et al. Risk of Fracture in Women with Type 2 Diabetes: the Women’s Health Initiative Observational Study. J Clin Endocr Metab. 2006;91(9):3404-10. doi: 10.1210/jc.2006-0614
  16. Shah VN, Shah CS, Snell-Bergeon JK. Type 1 diabetes and risk of fracture: meta-analysis and review of the literature. Diabet Med. 2015;32:1134-42.
  17. Weber DR, Haynes K, Leonard MB, et al. Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN). Diabetes Care. 2015;38:1913-20.
  18. Janghorbani M, Van Dam RM, Willett WC, Hu FB. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol. 2007;166:495-505.
  19. Holmberg AH, Johnell O, Nilsson PM, et al. Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int. 2006;17:1065-77.
  20. Ялочкина Т.О., Белая Ж.Е.,Рожинская Л.Я., и др. Переломы костей при сахарном диабете 2 типа: распространенность и факторы риска. Сахарный диабет. 2016;19(5):359-65
  21. Shahwan MJ, Khattab MH, Jairoun AA. Association of Serum Calcium Level with Waist Circumference and Other Biochemical Health-care Predictors among Patients with Type 2 Diabetes. J Pharm Bioallied Sci. 2019;11(3):292-8.

Copyright (c) 2021 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies